Skip to main content
. 2013 Jan;52(1):48–56.

Figure 2.

Figure 2.

Plasma concentration (mean ± 1 SD; n = 10) of (A) buprenorphine and its metabolites, (B) norbuprenorphine, (C) buprenorphine-3-glucuronide, and (D) norbuprenorphine-3-glucuronide, after a single intramuscular injection of LDB and HDB or subcutaneous injection of SRB.